neostigmine has been researched along with Coronary Artery Vasospasm in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kido, K | 1 |
Mizuta, K | 1 |
Mizuta, F | 1 |
Yasuda, M | 1 |
Igari, T | 1 |
Takahashi, M | 1 |
1 other study available for neostigmine and Coronary Artery Vasospasm
Article | Year |
---|---|
Coronary vasospasm during the reversal of neuromuscular block using neostigmine.
Topics: Cholinesterase Inhibitors; Coronary Vasospasm; Electrocardiography; Humans; Male; Middle Aged; Neost | 2005 |